The 3D bioprinting market is expected to reach US$6.9 billion by 2030, growing at a CAGR of 16.7% over the forecast period 2023-2030.

The global 3D bioprinting market was valued at US$2.3 billion in 2023 and is expected to reach US$6.9 billion by 2030, growing at a CAGR of 16.7% during the forecast period 2023-2030.

RICHMOND, Nov. 09, 2023 (GLOBE NEWSWIRE) — According to a research report “3D bioprinting marketby components (3D bioprinters and bioink), technology (stereolithography, selective laser sintering, electron beam melting, fused deposition modeling, fabrication of laminated objects, inkjet printing and multi-stage jet solidification), material type (living cells, Extracellular matrices and hydrogels), application (simulation models and surgical training, prosthetic devices, tissue engineering and regenerative medicine, orthopedic implants, dental implants, medical sensors etc.), end user (research organizations, academic institutes, biopharmaceutical companies, hospitals etc.) and region.

Global market for 3D bioprinting Scope of report:

Download the sample – https://www.marketdigits.com/request/sample/151

TOC covers depth and respiration 3D bioprinting market
172- Market data tables
63-List of numbers
220 – Pages

The report includes vendor assessment (company profiles, market positioning, strategies, recent developments, capabilities and product offerings/mapping), technology assessment (developments and economic impact), ecosystem of partners and customers (product services, propositions and key features), competitive benchmark and competitive indicators. Regional footprint by MarketDigits.

The story continues

Market overview

The global 3D bioprinting market is witnessing significant growth, driven by the convergence of technological developments and expanding applications in healthcare and biotechnology. This cutting-edge technology allows precise deposition of biomaterials and living cells layer by layer, forming 3D structures that mimic the complexity of human tissues and organs. The market expansion is due to growing demand for personalized medicine, organ transplantation solutions, and advances in regenerative medicine. The healthcare sector, in particular, is expected to benefit greatly from 3D bioprinting, as it has the potential to transform drug testing, disease modeling, and creating patient-specific implants. As R&D efforts ramp up, collaboration between academia, research institutions and industry stakeholders is increasing. Despite ongoing regulatory challenges, ongoing initiatives to establish standards and guidelines are contributing to the maturation of the market. The global 3D bioprinting market holds the promise of addressing critical medical challenges and enhancing patient outcomes, positioning itself for sustainable growth in the foreseeable future.

Key vendors in the global 3D bioprinting market – Envisiontec, Inc., Organovo, Inventia Life Science Pty Ltd, Poietis, Vivax Bio, LLC, Allevi, Cyfuse Biomedical KK, 3D Bioprinting Solutions, Cellink Global, Regemat 3D SL, BICO Group AB, Organovo Holdings Inc., CollPlant Biotechnologies Ltd Aspect Biosystems Ltd., Advanced Solutions Life Sciences, LLC, and Regenovo Biotechnology Co., Ltd. And others.

Discount Request @ https://www.marketdigits.com/request/discount/151

3D bioprinting is seeing a growing presence in the cosmetic and pharmaceutical industries

3D bioprinting is seeing a growing presence in the cosmetic and pharmaceutical industries. Many pharmaceutical companies are rapidly adopting 3D bioprinting technologies and products to accelerate the discovery and development of new drugs. Compared to traditional drug testing methods, 3D bioprinting provides a more cost-effective and safe approach to drug evaluation. By leveraging the 3D bioprinting approach, pharmaceutical companies can evaluate the effectiveness of drugs within hours, significantly reducing the typical three to six years required to develop new drugs. This innovative technology enables R&D teams to test new drugs in the early stages and during preclinical studies using 3D bioprinted tissue. Benefits include reduced reliance on animal testing, increased efficiency, and accelerated drug development. The increasing use of 3D printing promotes a deeper understanding of this technology, especially in the field of cosmetics. Furthermore, prompted by the European Commission’s ban on animal testing of cosmetics since March 2013, many organizations in the cosmetics and healthcare sectors are adopting 3D bioprinting to create advanced 3D tissue models and methodologies for drug screening.

Market dynamics

Drivers:

• Increased use of 3D bioprinting in the pharmaceutical and cosmetic industries

• Advances in 3D bioprinting for tissue and organ regeneration applications

• Increase public and private funding to support bioprinting research activities

• Technological advances in the 3D bioprinting industry

Opportunities:

• High demand for organ transplantation

• Growing awareness of 3D bioprinting

• Increasing demand for regenerative medicine and stem cell research

High demand for organ transplantation

The field of 3D bioprinting is rapidly expanding within the medical sector. This innovative process involves generating living tissues and organs based on computer-aided design models. Their ability to transform medical treatments is remarkable. By providing the ability to address the growing demand for organ transplants, which currently exceeds the availability of donor organs, 3D bioprinting could herald a revolutionary approach. This technology offers an ethical and effective way to manufacture organs suitable for transplantation. Moreover, it holds the promise of reducing expenses associated with organ transplantation procedures. As advances in improving this technology continue, the 3D bioprinting market is expected to witness significant growth in the coming years.

North America dominates the 3D bioprinting market.

In 2023, the North American 3D bioprinting market will gain a prominent share. This achievement was driven by technological advances, intensified research and development projects, and improvements in healthcare infrastructure. Furthermore, the region’s high healthcare spending, growing aging demographics, and high prevalence of chronic diseases are all factors promoting the adoption of this technology, particularly in the pharmaceutical sector. In addition, 2021 saw an approximate count of 90,000 kidney patients awaiting kidney transplants in the United States, with only 21.4% of them successfully undergoing a kidney transplant. In contrast, the number of individuals on waiting lists for liver, heart and lung transplants continues to rise within the country. According to official government statistics, the total number of individuals awaiting organ transplantation exceeded 105,000 in 2021. Furthermore, North America is experiencing a rapid rise in its elderly population along with a rising incidence of bone diseases. These factors are expected to contribute to the growing demand for bioprinted tissues in the region.

On the other hand, the Asia-Pacific region is poised to emerge as the fastest expanding market for 3D bioprinting, driven primarily by a large consumer base, escalating R&D efforts in this area, and government support combined with tax incentives. It is worth noting that Chinese researchers have made significant progress in this technology, which is embodied in the liquid printing process. This approach involves a mixture of liquid polymers to produce a stable membrane. These researchers assert that the resulting liquid structures can retain their shape for up to 10 days before undergoing fusion. Through this innovative technology, they succeeded in 3D printing complex shapes, laying the foundation for the biomanufacturing of tissues composed of living cells.

The inkjet printing segment is expected to hold the largest market share during the forecast period

Based on technology, the market is segmented into stereolithography, selective laser sintering, electron beam melting, fused deposition modeling, laminated object fabrication, inkjet printing, and multi-stage jet solidification. In 2023, the inkjet-based segment will dominate the technology sector with a larger share of revenue. This technology facilitates the printing of complex living organs or tissues on culture substrates, using biomaterials as bioinks. The prevalent use of inkjet-based printing in the medical field is a major factor driving the growth of this sector. This study highlights research trends in inkjet printing as a biologically applicable technology, especially in the areas of tissue engineering and drug delivery systems. The inkjet-based segment is expected to witness significant growth over the forecast period, driven by increasing demand and increased reliability.

To purchase this report directly @ https://www.marketdigits.com/checkout/151?lic=s

Similar reports we have on the healthcare industry:

Dental implants and prosthetics market 2030 by Type, Distribution Channel, End User and Region – Partner and Customer Ecosystem (Product Services, Offerings and Key Features) Competitive Index and Regional Footprint by MarketDigits

Al Ain Agriculture Market 2030 by Type, Distribution Channel, End User and Region – Partner and Customer Ecosystem (Product Services, Offerings and Key Features) Competitive Index and Regional Footprint by MarketDigits

Dental 3D printing market 2023 – 2030 by technology (photovoltaic polymerization, FDM, SLS, Polyjet), product (materials (plastics, metals), equipment (scanner, 3D printers), service), application (prosthodontics, dental implants), end user (laboratories) , Hospitals) – Partner and Customer Ecosystem (Product Services, Offerings and Key Features) Competitive Index and Regional Footprint by MarketDigits

About MarketDigits:

MarketDigits is a leading business research and consulting firm that helps clients exploit new and emerging opportunities and revenue areas, thus helping them in making operational and strategic decisions. We at MarketDigits believe that the market is a small place and an interface between the supplier and the consumer, hence our focus remains primarily on business research that includes the entire value chain and not just markets.

We provide the most convenient and useful services to users, which helps businesses sustain themselves in this competitive market. Our detailed and in-depth market analysis that meets the strategic, tactical and operational data analysis and reporting needs of various industries uses advanced technology so that our clients can gain better market insights and identify profitable opportunities and additional revenue areas.

call us:
Market numbers
1248 Carmia Road Richmond,
FA 23235,
United State.
USA: +1 847 450 0808
e-mail: sales@marketdigits.com
Web: https://www.marketdigits.com

Follow us on: | Twitter | LinkedIn